HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study.
Saved in:
| Title: | HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. |
|---|---|
| Authors: | Chang, Xu1 (AUTHOR), Li, Xinge2 (AUTHOR), Sun, Peng1 (AUTHOR), Li, Zhenfeng1 (AUTHOR), Sun, Pengfei3 (AUTHOR) drsunpengfei@sina.com, Ning, Shangkun4 (AUTHOR) ningskun@163.com |
| Source: | BMC Cancer. 4/16/2024, Vol. 24 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 176651432 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chang%2C+Xu%22">Chang, Xu</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Xinge%22">Li, Xinge</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Peng%22">Sun, Peng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Li%2C+Zhenfeng%22">Li, Zhenfeng</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sun%2C+Pengfei%22">Sun, Pengfei</searchLink><relatesTo>3</relatesTo> (AUTHOR)<i> drsunpengfei@sina.com</i><br /><searchLink fieldCode="AR" term="%22Ning%2C+Shangkun%22">Ning, Shangkun</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> ningskun@163.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22BMC+Cancer%22">BMC Cancer</searchLink>. 4/16/2024, Vol. 24 Issue 1, p1-11. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=176651432 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12885-024-12233-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1 Titles: – TitleFull: HAIC Combined with lenvatinib plus PD-1 versus lenvatinib Plus PD-1 in patients with high-risk advanced HCC: a real-world study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chang, Xu – PersonEntity: Name: NameFull: Li, Xinge – PersonEntity: Name: NameFull: Sun, Peng – PersonEntity: Name: NameFull: Li, Zhenfeng – PersonEntity: Name: NameFull: Sun, Pengfei – PersonEntity: Name: NameFull: Ning, Shangkun IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 04 Text: 4/16/2024 Type: published Y: 2024 Identifiers: – Type: issn-print Value: 14712407 Numbering: – Type: volume Value: 24 – Type: issue Value: 1 Titles: – TitleFull: BMC Cancer Type: main |
| ResultId | 1 |